Cannabinoid Receptor 1 (CB1 or CANN6 or CNR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Atrial Natriuretic Peptide Receptor 1 (Atrial Natriuretic Peptide Receptor Type A or Guanylate Cyclase A or NPR1 or EC 4.6.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
PharmaSphere: US Healthcare Policy Update – Impact Analysis of the Affordable Care Act on Stakeholders